{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:38:32Z","timestamp":1789706312246,"version":"4.0.1"},"reference-count":24,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2148","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T11:50:21Z","timestamp":1353412221000},"page":"637-645","source":"Crossref","is-referenced-by-count":40,"title":["Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance"],"prefix":"10.3892","volume":"29","author":[{"given":"WEI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAN","family":"LING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIE","family":"TAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIEQING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,11,20]]},"reference":[{"key":"key20180107214458_b1-or-29-02-0637","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GRF.0b013e3181961625","article-title":"Ovarian cancer: detection and radiologic staging","volume":"52","author":"Shaaban","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"key20180107214458_b2-or-29-02-0637","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11670-011-0003-9","article-title":"Cancer incidence and mortality in China, 2006","volume":"23","author":"Chen","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"key20180107214458_b3-or-29-02-0637","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1160\/TH10-01-0017","article-title":"Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling","volume":"104","author":"Colman","year":"2010","journal-title":"Thromb Haemost"},{"key":"key20180107214458_b4-or-29-02-0637","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.thromres.2009.11.034","article-title":"Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment","volume":"125","author":"Gramling","year":"2010","journal-title":"Thromb Res"},{"key":"key20180107214458_b5-or-29-02-0637","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1160\/TH08-04-0266","article-title":"Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1)","volume":"100","author":"Lademann","year":"2008","journal-title":"Thromb Haemost"},{"key":"key20180107214458_b6-or-29-02-0637","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.2741\/1754","article-title":"The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1)","volume":"1","author":"Suelves","year":"2005","journal-title":"Front Biosci"},{"key":"key20180107214458_b7-or-29-02-0637","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/annonc\/mdq462","article-title":"Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer","volume":"22","author":"Dorn","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180107214458_b8-or-29-02-0637","first-page":"599","article-title":"New prognostic and predictive factors in breast cancer","volume":"62","author":"Schmidt","year":"2010","journal-title":"Minerva Ginecol"},{"key":"key20180107214458_b9-or-29-02-0637","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4149\/neo_2011_05_377","article-title":"Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients","volume":"58","author":"Halamkova","year":"2011","journal-title":"Neoplasma"},{"key":"key20180107214458_b10-or-29-02-0637","first-page":"562481","article-title":"PAI-1: an integrator of cell signaling and migration","author":"Czekay","year":"2011","journal-title":"Int J Cell Biol"},{"key":"key20180107214458_b11-or-29-02-0637","first-page":"312","article-title":"Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer","volume":"26","author":"Cai","year":"2007","journal-title":"Ai Zheng"},{"key":"key20180107214458_b12-or-29-02-0637","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<588::AID-IJC6>3.0.CO;2-W","article-title":"High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma","volume":"79","author":"Borgfeldt","year":"1998","journal-title":"Int J Cancer"},{"key":"key20180107214458_b13-or-29-02-0637","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1017542915662","article-title":"Urokinase and tissue plasminogen activators and their inhibitor PAI-1 in human tumors","volume":"131","author":"Gershtein","year":"2001","journal-title":"Bull Exp Biol Med"},{"key":"key20180107214458_b14-or-29-02-0637","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3325\/cmj.2008.2.175","article-title":"Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells","volume":"49","author":"Wang","year":"2008","journal-title":"Croat Med J"},{"key":"key20180107214458_b15-or-29-02-0637","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1074\/jbc.M100181200","article-title":"Integrin alpha(v)beta(3)\/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells","volume":"276","author":"Hapke","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107214458_b16-or-29-02-0637","first-page":"3958","article-title":"Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2","volume":"55","author":"Schmalfeld","year":"1995","journal-title":"Cancer Res"},{"key":"key20180107214458_b17-or-29-02-0637","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1158\/1078-0432.CCR-06-2482","article-title":"imary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients","volume":"13","author":"Dorn","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107214458_b18-or-29-02-0637","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<449::AID-IJC1>3.0.CO;2-0","article-title":"Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients","volume":"9","author":"Chambers","year":"1998","journal-title":"Int J Cancer"},{"key":"key20180107214458_b19-or-29-02-0637","first-page":"2372","article-title":"Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo","volume":"54","author":"Achbarou","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107214458_b20-or-29-02-0637","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/annonc\/10.suppl_4.S46","article-title":"Gress TM1 invasion and metastasis in pancreatic cancer","volume":"10","author":"Ellenrieder","year":"1999","journal-title":"Ann Oncol"},{"key":"key20180107214458_b21-or-29-02-0637","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s000180050497","article-title":"The plasminogen activation system in tumor growth, invasion, and metastasis","volume":"57","author":"Andreasen","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"key20180107214458_b22-or-29-02-0637","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M011085200","article-title":"Targeting of tumor by cell surface urokinase plasminogen activator-dependent anthrax toxin","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107214458_b23-or-29-02-0637","first-page":"2661","article-title":"Urokinase plasminogen activator\/urokinase specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p382 mitogen-activated protein kinase activity","volume":"275","author":"Huang","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107214458_b24-or-29-02-0637","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.122.3.673","article-title":"Upregulation of urokinase receptor expression on migrating endot helial cells","volume":"122","author":"Pepper","year":"1993","journal-title":"J Cell Biol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2148\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T20:36:21Z","timestamp":1562358981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,20]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,11,20]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2148"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2148","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,20]]}}}